For media inquires, please email press@juul.com.
For international inquiries, please email media@juul.co.uk.
March 10, 2025
Juul Labs is pleased to announce a final resolution with the State of Florida. Importantly, this agreement will fund efforts to combat the illegal…
March 5, 2025
Juul Labs is pleased to announce that on March 3, 2025, the U.S. International Trade Commission (ITC) issued a decision to terminate Altria’s patent…
February 3, 2025
Juul Labs, Inc., an American technology and innovation company, commends President Trump’s efforts to protect American citizens through increased enforcement of trade laws and…
January 29, 2025
The U.S. International Trade Commission (ITC) issued a decision today affirming an Administrative Law Judge’s ruling that Altria’s NJOY ACE e-vapor products infringe four…
January 15, 2025
The FDA’s 2017 Comprehensive Plan laid out a powerful roadmap for reducing smoking rates in America and the associated premature death and disease caused…
October 25, 2024
On October 21, Juul Labs’ Vice President of U.S. Regulatory Affairs, Robyn Gougelet, delivered remarks during a joint public meeting hosted by the U.S….
October 2, 2024
On September 26th, Juul Labs’ Chairman & Chief Executive Officer, K.C. Crosthwaite, delivered the keynote address at the 2024 Global Tobacco & Nicotine Forum,…
September 6, 2024
Juul Labs is encouraged to see another year of continued decline in underage use of vapor products in general, and JUUL products specifically. Overall,…
July 29, 2024
Juul Labs announced today the settlement with a group of noteholders that confirms the conversion of the convertible notes to equity, and provides an…
June 6, 2024
Today, the FDA rescinded its June 2022 Marketing Denial Orders (MDOs) for the JUUL System and placed our applications back into scientific review. We appreciate the FDA’s decision and now look forward to re-engaging with the agency on a science- and evidence-based process to pursue a marketing authorization for JUUL products.